Federal Policy

‘A Shocking Amount of Misery’: Medical Debt in America

We talk about the impact medical debt can have on people’s lives and what research tells us about possible solutions.

Read More

Medicare’s Prescription Drug Plan Makeover Transcript

‘Medicare’s Prescription Drug Plan Makeover’ Transcript October 27, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in Apple Podcasts Listen on Spotify…

Read More

Medicare’s Prescription Drug Plan Makeover 

An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.

Read More

Medicare Open Enrollment

Leslie Walker shares four research studies to explain the stakes of Medicare open enrollment.

Read More

The Next Chapter in Democratizing America’s Health Data

We talk with Micky Tripathi, the National Coordinator for Health Information Technology, about the push to give patients more access to their health care data.

Read More

The Push to End Cancer Screening Purgatory

Initial screenings for breast, lung and cervical cancer are free, but expensive secondary tests can leave patients in screening purgatory.

Read More

Streamlining Access to the Safety Net

Paul Shafer highlights newly federal rule aimed at streamlining application and renewal processes for enrolling in Medicaid and CHIP.

Read More

The Race to Prepare for Medicare’s New Drug Pricing Powers

Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

Read More

Breaking Down Biden’s New Nondiscrimination Rule

Katie Keith shares about a newly proposed rule to Section 1557, a civil rights pillar of the Affordable Care Act.

Read More

Dems’ New Drug Pricing Deal: What You Need to Know

Stacie Duestzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.

Read More